Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

551 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
Johansson H, Gandini S, Bonanni B, Mariette F, Guerrieri-Gonzaga A, Serrano D, Cassano E, Ramazzotto F, Baglietto L, Sandri MT, Decensi A. Johansson H, et al. Among authors: serrano d. Breast Cancer Res Treat. 2008 Mar;108(1):57-67. doi: 10.1007/s10549-007-9577-9. Epub 2007 Apr 28. Breast Cancer Res Treat. 2008. PMID: 17468953
Breast cancer prevention trials using retinoids.
Decensi A, Serrano D, Bonanni B, Cazzaniga M, Guerrieri-Gonzaga A. Decensi A, et al. Among authors: serrano d. J Mammary Gland Biol Neoplasia. 2003 Jan;8(1):19-30. doi: 10.1023/a:1025779120649. J Mammary Gland Biol Neoplasia. 2003. PMID: 14587861 Review.
Pharmacological prevention of breast cancer: quo vadis?
Serrano D, Bonanni B, Cazzaniga M, Galli A, Gonzaga AG, Decensi A. Serrano D, et al. Breast. 2003 Dec;12(6):379-86. doi: 10.1016/s0960-9776(03)00140-1. Breast. 2003. PMID: 14659109 Review.
Progress in chemoprevention of breast cancer.
Serrano D, Perego E, Costa A, Decensi A. Serrano D, et al. Crit Rev Oncol Hematol. 2004 Feb;49(2):109-17. doi: 10.1016/S1040-8428(03)00157-4. Crit Rev Oncol Hematol. 2004. PMID: 15012972 Review.
Chemoprevention of colorectal cancer: an update.
Serrano D, Lazzeroni M, Decensi A. Serrano D, et al. Tech Coloproctol. 2004 Dec;8 Suppl 2:s248-52. doi: 10.1007/s10151-004-0170-5. Tech Coloproctol. 2004. PMID: 15666100 Review.
Effect of the synthetic retinoid fenretinide on circulating free prostate-specific antigen, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 levels in men with superficial bladder cancer.
Serrano D, Baglietto L, Johansson H, Mariette F, Torrisi R, Onetto M, Paganuzzi M, Decensi A. Serrano D, et al. Clin Cancer Res. 2005 Mar 1;11(5):2083-8. doi: 10.1158/1078-0432.CCR-04-1549. Clin Cancer Res. 2005. PMID: 15756035 Clinical Trial.
Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women.
Guerrieri-Gonzaga A, Robertson C, Bonanni B, Serrano D, Cazzaniga M, Mora S, Gulisano M, Johansson H, Formelli F, Intra M, Latronico A, Franchi D, Pelosi G, Johnson K, Decensi A. Guerrieri-Gonzaga A, et al. Among authors: serrano d. J Clin Oncol. 2006 Jan 1;24(1):129-35. doi: 10.1200/JCO.2005.02.9934. J Clin Oncol. 2006. PMID: 16382122 Clinical Trial.
551 results